Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02163577
Brief Title: Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

First Submitted : June 9, 2014
First Submitted that Met QC Criteria : June 11, 2014
First Posted : June 13, 2014 (Estimate)

Results First Submitted : April 29, 2019
Results First Submitted that Met QC Criteria : April 29, 2019
Results First Posted : May 22, 2019

Certification/Extension First Submitted : July 14, 2017
Certification/Extension First Submitted that Met QC Criteria : July 14, 2017
Certification/Extension First Posted : July 18, 2017

Last Update Submitted that Met QC Criteria : July 8, 2019
Last Update Posted : July 18, 2019